Blueprint Medicines Corporation (BPMC)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 38.78M | 63.29M | 57.57M | 56.57M | 71.96M | 96.12M | 138.16M | 128.19M |
営業利益 | -149.8M | -124.21M | -129.28M | -128.98M | -105.11M | -78.82M | -43.05M | -48.01M |
税引前収入 | -157.61M | -129.04M | -132.6M | -133.52M | -110.86M | 89.32M | -49.89M | -56M |
純利益 | -158.65M | -129.56M | -132.79M | -133.71M | -110.92M | 89.14M | -50M | -56.27M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -148.37M | -123.22M | -129.9M | -129.35M | -105.69M | -78.45M | -43.05M | -48.01M |
EBITDA | -148.02M | -120.52M | -125.7M | -126.11M | -103.58M | -74.01M | -39.43M | -44.15M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 27.77M | 21.43M | 44.52M | 66.51M | 793.74M | 180.08M | 204.04M | 249.38M |
営業利益 | -72.58M | -151.25M | -247.03M | -361.33M | 308.71M | -641.98M | -537.52M | -486.28M |
税引前収入 | -72.5M | -148.12M | -236.64M | -347.69M | 314.94M | -641.08M | -552.28M | -506.02M |
純利益 | -72.5M | -148.12M | -236.64M | -347.69M | 313.88M | -644.09M | -557.52M | -506.98M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.189 | -3.399 | -5.374 | -7.057 | 5.431 | -10.891 | -9.298 | -8.34 |
EBIT | -72.03M | -147.9M | -236.57M | -347.59M | 308.34M | -642.37M | -535.51M | -487.22M |
EBITDA | -71M | -149.67M | -242.78M | -356.07M | 315.27M | -635.5M | -531.02M | -474.61M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約